20523 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
Medicinal plant extract
#2402Glycan therapeutics and related methods thereof
#2403Rutin-rich extract and method of making same
#2404Compositions comprising rutin useful for the treatment of tumors resistant to chemotherapy
#2405Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders
#2406Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders
#2407COMPOSITIONS AND METHODS USING ANTI-CS1 ANTIBODIES TO TREAT MULTIPLE MYELOMA
#2408Immunogenic compositions and methods for pigeon fever
#2409ANTI-OBESITY COMPOSITION
#2410CLOCK GENE EXPRESSION LEVEL REGULATOR
#2411RAPIDLY-DISSOLVING THIN FILM FORMULATION OF WATER SOLUBLE DIGITALIS GLYCOSIDE FOR THE TREATMENT OF CONGESTIVE HEART DISEASE
#2412Pharmaceutical composition for treating or preventing neuropsychiatric disease, containing flavone-6-C-glucose derivatives as active ingredients
#2413Antifungal topical composition and methods of treatment
#2414Cosmetic or dermatological compositions combining cosmetiques retinaldehyde and glycylglycine oleamide and the cosmetic or dermatological uses thereof
#2415Purified extract (ATC2) isolated from var. containing abundant amount of active ingredient, the preparation thereof, and the composition comprising the same as an active ingredient for preventing or treating inflammation, allergy and asthma
#2416METHODS FOR PREDICTING DRUG RESPONSIVENESS IN CANCER PATIENTS
#2417Treatment of rhinosinusitis with P-glycoprotein inhibitors
#2418Ulmoside-A: Useful For Prevention Or Cure Of Metabolic Diseases
#2419METHODS FOR ADMINISTERING WEIGHT LOSS MEDICATIONS
#2420Molecular Combinations for Cancer or Other Disease Treatment
#2421TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA WITH IVERMECTIN
#2422ORAL ADMINISTRATION OF ANTHOCYANINS, ANTHOCYANIDINS, AND THEIR METABOLITES FOR THE TREATMENT OF INFLAMMATION IN AN INFLAMMED JOINT
#2423THE USE OF SPINOSYNS AND SPINOSYN COMPOSITIONS AS LOCAL ANESTHETICS AND AS ANTIARRHYTHMIC AGENTS
#2424Compounds, compositions and methods using E-selectin antagonists for mobilization of hematopoietic cells
#2425INHIBITORS AND ENHANCERS OF URIDINE DIPHOSPHATE-GLUCURONOSYLTRANSFERASE 2B (UGT2B)
#24264-methylumbelliferone treatment for immune modulation
#2427Extruded chewable formulation comprising bound water
#2428TREATMENT OF PAPULOPUSTULAR ROSACEA WITH IVERMECTIN
#2429Treatment of leukemia with artemisinin derivatives and combinations with other antineoplastic agents
#2430MASITINIB FOR TREATING GASTRIC CANCER
#2431TREATMENT OF DISEASES ASSOCIATED WITH MOLD AND MYCOTOXIN EXPOSURE
#2432Methods and compositions for enhancing targeted transgene integration
#2433Topical compositions and methods for reducing oxidative stress
#2434KIT FOR CO-ADMINISTRATION OF DRUGS
#2435Nanoparticles and methods of producing the same
#2436Diagnosis and therapy of cancer involving cancer stem cells
#2437PHARMACEUTICAL, WATER-SOLUBLE AND ANTIFUNGAL MACROMOLECULAR COMPOUND
#2438Method of extracting flavonoids and/or polyphenols from dried and powdered citrus peels, compositions therefrom, and methods of treatment of diseases associated with chronic inflammation
#2439Laser assisted wound healing protocol and system
#2440PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#2441Treatment of papulopustular rosacea with ivermectin
#2442Compositions and methods of treatment of cancers
#2443Probiotic recolonisation therapy
#2444Probiotic recolonisation therapy
#2445Probiotic recolonisation therapy
#2446Probiotic recolonisation therapy
#2447SMALL MOLECULE MODULATORS OF P53 FAMILY SIGNALING
#2448Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis
#2449Methods for treating thrombocytopenia
#2450Vaporized medicants and methods of use
#2451Treatment for migraine
#2452TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA WITH IVERMECTIN
#2453Cardiac glycoside analogs and their use in methods for inhibition of viral infection
#2454Combination of pentacyclic triterpenes and hydroxytyrosol and derivatives thereof
#2455Methods and Compositions for Treating Clostridium difficile Associated Disease
#2456Molecular and Herbal Combinations for Disease Therapy
#2457Use of cilastatin to reduce the nephrotoxicity of different compounds
#2458Rhomboid Proteins and Uses Thereof
#2459Process For The Preparation Of A Non-Corrosive Base Solution And Methods Of Using Same
#2460Methods for treating neutropenia
#2461Composition and method for compounded therapy
#2462METHOD OF APPLYING A COMPOSITION AND PHARMACEUTICAL COMPOSITION WITH A REGIMEN OF ADMINISTERING IT
#2463Composition for enhancing semen quality in a male subject
#2464METHODS FOR MANIPULATING IMMUNE RESPONSES BY ALTERING MICROBIOTA
#2465COMPOSITIONS FOR USE IN CARTILAGE BREAKDOWN
#2466Compositions and methods for inhibiting leishmania
#2467PARASITICIDAL COMPOUNDS, METHODS, AND FORMULATIONS
#2468Methods of treating a gastrointestinal spasm associated with chemotherapy or radiation therapy
#2469Compositions And Methods For Immunotherapy
#2470Therapy for inhibition of single-stranded RNA virus replication
#2471Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
#2472Compositions for delivery of drug combinations
#2473ENVIRONMENTAL CLOSTRIDIAL BACTERIOTHERAPY AND RELATED FORMULATIONS AND METHODS OF MANUFACTURE AND USE
#2474EPIGENETIC MECHANISMS OF ANTI-FIBROTIC ACTION FOR THE LIVER
#2475Use of Cysteamine in Treating Infections caused by Yeasts/Moulds
#2476Liquid pharmaceutical composition for the treatment of a posterior eye disease
#2477Composition for preventing, relieving or treating colitis, containing complex extracts
#2478Single Dose Oral Formulations and Methods for Treatment of Cats with Ectoparasiticidal Spinosad
#2479Compositions comprising nanoparticles and apoptotic agents and methods of use
#2480COMPOSITIONS FOR USE IN CARTILAGE BREAKDOWN
#2481Method of determining acute myeloid leukemia response to treatment with farnesyltransferase inhibitors
#2482ANIMAL TREATMENTS
#2483Synthetic lethality in cancer
#2484Biodefenses using triazole-containing macrolides
#2485Anti-wall teichoic antibodies and conjugates
#2486INNOVATIVE METHODS OF TREATMENTING TUBERCULOSIS
#2487PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF METABOLIC DISORDERS
#2488Compositions and methods for the reduction or prevention of hepatic steatosis
#2489CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY
#2490Targeted delivery of anti-fungal agents
#2491Methods for treating scars and aging skin
#2492Compositions for the treatment of peripheral ulcers of various origins
#2493MAILLARD REACTION INHIBITOR
#2494Methods of making a deuterated or a non-deuterated molecule and pharmaceutical formulations for treatment
#2495Composition comprising a purified extract isolated from var. containing abundant amount of active ingredient or the compounds isolated therefrom, as an active ingredient for treating a chronic obstructive pulmonary disease and the use thereof
#2496COMPOSITIONS TO ALLEVIATE PRESYSTEMIC METABOLISM OF OPIOIDS
#2497Stable veterinary combination formulations of macrocyclic lactones and imidazothiazoles
#2498Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
#2499Use of a macrocyclic lactone for treating a complication from a papilloma virus infection
#2500Novel Dispersible Tablet Composition
#2501Composition of tiacumicin compounds
#2502TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST
#2503Compositions for use in stimulating bone growth
#2504Oligonucleotides for modulating gene expression and uses thereof
#2505Metal chelating compositions and methods for controlling the growth or activities of a living cell or organism
#2506Treatment of myocardial infarction by inhibiting the action of mAKAPβ
#2507PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#2508Pharmaceutical composition, methods for treating and uses thereof
#2509Pharmaceutical composition, methods for treating and uses thereof
#2510Apparatus and method for correction of erectile dysfunction
#2511EXTENDED-RELEASE TOPIRAMATE CAPSULES
#2512Quinazolinone antibiotics
#2513IMMUNE-POTENTIATING DRUG NANOCARRIERS AND METHODS OF PRODUCTION AND USE THEREOF
#2514Flavonoid-based composition for pharmaceutical, nutritional or cosmetic use having potentiated antioxidant action
#2515Cancer therapy
#2516Controlled drug release liposome composition
#2517Process for producing a particulate composition comprising an hydrous crystalline 2-O-α-D-glucosyl-L-ascorbic acid
#2518Pomegranate fruit polyphenol composition and methods of use and manufacture thereof
#2519Etoposide and prodrugs thereof for use in targeting cancer stem cells
#2520COMPOSITIONS AND METHODS FOR TREATING DISEASE STATES ASSOCIATED WITH ACTIVATED T CELLS AND/OR B CELLS
#2521Sustained-release formulations of topiramate
#2522BIOADHESIVE AND BIODEGRADABLE AND FORMULATIONS THAT PROVIDE SUSTAINED RELEASE OF ANTIMICROBIALS, BACTERIOPHAGES AND ANTI-INFLAMMATORY MEDICATIONS FOR INACTIVATION OF BIOFILMS AND THE TREATMENT OF RHINOSINUSITIS AND OTHER INFECTIONS
#2523Liquid compositions capable of foaming and including active agents, and methods for making or developing same
#2524Methods to protect against and treat multiple sclerosis
#2525SYSTEM, RETAINER AND METHOD OF PROVIDING THERAPEUTIC TREATMENT FOR ACNE
#2526Treatment of Pulmonary Hypertension with Carbonic Anhydrase Inhibitors
#25274-CYANO-N-(2-(4,4-DIMETHYLCYCLOHEX-1-EN-1-YL)-6-(2,2,6,6-TETRAMETHYLTETRAHYDRO-2H-PYRAN-4-YL)PYRIDIN-3-YL)-1H-IMIDAZOLE-2-CARBOXAMIDE FOR THE TREATMENT OF HODGKIN'S LYMPHOMA
#2528Methods and compositions for increasing antibiotic activity
#2529Dental and medical devices with light source and antimicrobial solution
#2530Nutritional supplement/feed formula and methods of use thereof to reduce development of Osteochondrosis Dissecans (OCD) lesions
#2531TRANSDERMAL FORMULATIONS
#2532Methods and Compositions for the Prevention and Treatment of Parasitic Disease
#2533Process For The Preparation Of A Non-Corrosive Base Solution And Methods Of Using Same
#2534COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY
#2535AGENTS AND DEVICES FOR AFFECTING NERVE FUNCTION
#2536PHARMACEUTICAL COMPOSITIONS FOR INHIBITING ANGIOGENESIS
#2537Compositions for anti-inflammatory, antioxidant effects and improved respiratory function by specific histone deacetylase inhibition
#2538Anti-cancer compounds from invasive salvinias and methods of treating cancer
#2539Pharmaceutical Compositions for Rectal Administration
#2540PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#2541Compositions and methods for treating psychiatric disorders
#2542Antiviral activity from medicinal mushrooms and their active constituents
#2543Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof
#2544Methods of treating topical microbial infections
#2545Combinations of Oral Medicaments Bonded by a Wrapping
#2546Milk-derived microvesicle compositions and related methods
#2547Oral antiseptic composition useful for treating oral mucositis
#2548Biologically active macrolides, compositions, and uses thereof
#2549D-fagomine for the control of inflammatory processes related to an overactivation of the humoral immune response
#2550METHOD FOR PRODUCING A MICROENCAPSULATE AND CORRESPONDING REACTIVE AMPHIPHILIC COMPOUND, MICROENCAPSULATE AND COMPOSITION
#2551Anti-wall teichoic antibodies and conjugates
#2552COMPOSITIONS AND METHODS FOR TREATING FUNGAL INFECTIONS
#2553Selamectin for treatment of sea lice infestations
#2554Rapidly dispersible dosage form of topiramate
#2555METHODS AND ASSAYS RELATING TO RNF216
#2556Compounds, extracts and methods from chinese medicinal herb sophora flavescens that inhibit airway contraction
#2557PROPHYLACTIC/THERAPEUTIC AGENT FOR DRY EYE
#2558Use of cannabinoids in the treatment of epilepsy
#2559Use of cannabinoids in the treatment of epilepsy
#2560EDIBLE COMPOSITION COMPRISING AN EXTRACT OF INULA RACEMOSA AND NARINGIN
#2561Method of inhibiting ABCG2 and related treatments
#2562Parenteral formulations for administering macrolide antibiotics
#2563Na/K-ATPase ligand and uses thereof in wound healing
#2564Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibition
#2565External dermal composition for anti-ageing and method for producing the same
#2566Rufinamide and derivatives and their use in modulating the gating process of human voltage-gated sodium channels
#2567Method for producing polyphenol composition
#2568Treatment of Diseases Using Combination of Ultraviolet Blood Irradiation and Antibiotics
#2569C-terminal HSP90 inhibitors to treat pituitary adenomas
#2570NERVE GROWTH INHIBITOR, CUTANEOUS-SENSORY-IRRITATION INHIBITOR, AND MARKER FOR CUTANEOUS-SENSORY-IRRITATION DETECTION
#2571DRUG DELIVERY VEHICLES
#2572Enteric combination therapy
#2573Extract of for reducing blood sugar, reducing blood fat, treating leukemia, and preparation method and uses thereof
#2574Methods of inducing read-through of a nonsense mutation associated with ataxia telangiectasia, Rett syndrome or spinal muscular atrophy by erythromycin or azithromycin
#2575ORALLY ADMINISTRATABLE FORMULATIONS FOR THE CONTROLLED RELEASE OF A PHARMACOLOGICALLY ACTIVE AGENT
#2576Agents for Eliminating Tumour-Initiating Cells
#2577Skin-moisturising or wrinkle-improving external composition and cosmetic composition
#2578Composition for cognitive and cosmetic purposes
#2579Compositions and methods for topical diagnostic and therapeutic transport
#2580Methods and assays for combination treatment of cancer
#2581Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycoside
#2582Use of tylvalosin as antiviral agent
#2583NEW APPLICATION OF CATALPOL
#2584Edible composition comprising resveratrol and flavonoid monoglucoside
#2585Dry pharmaceutical compositions for topical delivery of oral medications, nasal delivery and to treat ear disorders
#2586Near-Infrared Electromagnetic Modification of Cellular Steady-State Membrane Potentials
#2587Compositions for Delivering Drugs with Low Water Solubility
#2588Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
#2589Probiotic recolonisation therapy
#2590Probiotic recolonisation therapy
#2591Probiotic recolonisation therapy
#2592TOPICAL APPLICATION OF IVERMECTIN FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS/AFFLICTIONS
#2593Use of ivermectin and derivatives thereof
#2594APP specific BACE inhibitors (ASBIs) and uses thereof
#2595Use of maleimide derivatives for preventing and treating leukemia
#2596TOPICAL APPLICATION OF IVERMECTIN FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS/AFFLICTIONS
#2597COCHLEATES MADE WITH SOY PHOSPHATIDYLSERINE
#2598Compositions and method for light triggered release of materials from nanovesicles
#2599Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines
#2600Sterile otic formulations
#2601Selective targeting agents for mitochondria
#2602Small molecule substance for improving sensitivity of bacteria to antibiotics
#2603Inhalation-type pharmaceutical composition for the treatment of lung cancer and preparation method thereof
#2604Antimicrobial articles produced by additive manufacturing
#2605Phenolic compositions derived from apple skin and uses thereof
#2606Nutraceutical Composition Obtained from Fungus-Challenged Soy Seedlings
#2607COMPOSITION FOR TREATING METABOLIC DISORDERS
#2608METHODS OF PREVENTING TUMOR METASTASIS, TREATING AND PROGNOSING CANCER AND IDENTIFYING AGENTS WHICH ARE PUTATIVE METASTASIS INHIBITORS
#2609DRUG COMPOSITION FOR TREATING TUMORS AND APPLICATION THEREOF
#2610COMPOSITION FOR INHIBITING CELLULAR SENESCENCE COMPRISING QUERCETIN-3-O-beta-D-GLUCURONIDE
#2611Compositions for alleviating inflammation and oxidative stress in a mammal
#2612Controlled Release Systems of Pluribioactive Antifungal Drugs
#2613ANTICANCER AGENT, AND COMBINATION USE ANTICANCER AGENT
#2614Antibiotic methods and compositions for bacteria infections
#2615Transdermal parasiticidal formulations
#2616Hyaluronic Acid Decomposition-Promoting Factor and Inhibitor Thereof
#2617Physical Optimization Beverage
#2618Treatment of metabolic disorders in equine animals
#2619Antiviral supplement formulations
#2620Glucopyranosyl derivatives and their uses in medicine
#2621THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING DIABETES
#2622Composition for prevention, amelioration or treatment of metabolic syndrome
#2623THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING DIABETES UTILIZING DITERPENOID COMPOUNDS
#2624Extended-release topiramate capsules
#2625Tylosin A analogs and derivatives
#2626Flavonoid compounds and uses thereof
#2627Specific delivery of toxins conjugated with antibodies to activate matripase
#2628BIODEGRADABLE POLYMERIC BUFFERS
#2629PURIFIED LIMONIN GLUCOSIDE FOR PREVENTION AND TREATMENT OF CHRONIC DISEASES
#2630LIPID COATED NANOPARTICLES CONTAINING AGENTS HAVING LOW AQUEOUS AND LIPID SOLUBILITIES AND METHODS THEREOF
#2631Therapeutic or preventive agent for meibomian gland dysfunction or meibomian gland blockage
#2632Probiotic recolonisation therapy
#2633Microbiota restoration therapy (MRT), compositions and methods of manufacture
#2634Alginate oligomers for use in overcoming multidrug resistance in bacteria
#2635Treatment of sickle cell disease and inflammatory conditions
#2636Diagnosis and treatment of invasive aspergillosis
#2637Method for restoring male sex drive (libido)
#2638SIRTUIN GENE POTENTIATOR, AND PHARMACEUTICAL PRODUCT, COSMETIC PRODUCT, AND FOOD PRODUCT USING SAME
#2639COMPOSITION FOR PREVENTING OR TREATING COLITIS
#2640FRUCTOSE ABSORPTION INHIBITOR
#2641Manufacturing method for polyphenol composition
#2642COMPOUNDS AND METHODS FOR SELECTIVELY TARGETING CANCER STEM CELLS
#2643METHODS AND USES OF AN EXTRACT FROM OLIVE LEAF IN MANAGEMENT OF TYPE 2 DIABETES
#2644Solid Carriers for Improved Delivery of Active Ingredients in Pharmaceutical Compositions
#2645Process for manufacturing chewable dosage forms for drug delivery and products thereof
#2646ANTIPARASITIC POLYANHYDRIDE NANOPARTICLES
#2647Compositions for oral administration to animals, production methods thereof and uses of same
#2648Aqueous drug delivery system
#2649Antibacterial composition for topical use
#2650DUAL-TARGETING DRUG CARRIER AND METHOD FOR FABRICATING THE SAME
#2651Glycosyltransferase gene and use thereof
#2652HDC Activation Inhibitor, HDC Activation Inhibition Composition, Antipruritic Agent, and Antipruritic Agent Composition
#2653AGENTS, METHODS, AND DEVICES FOR AFFECTING NERVE FUNCTION
#2654Compounds and methods for treating bacterial infections
#2655Compounds, compositions and methods for protecting brain health in neurodegenerative disorders
#2656Anti-cancer agent
#2657Methods of treating drug side-effects that include a gastrointestinal spasm
#2658Composition for prevention, amelioration or treatment of metabolic syndrome
#2659Method of making an anhydrous, fat soluble, chewable drug delivery formulation
#2660FILAGGRIN PRODUCTION PROMOTER, THERAPEUTIC AGENT FOR DISEASES ASSOCIATED WITH REDUCTION IN PRODUCTION OF FILAGGRIN, AND METHOD FOR SCREENING FOR SAID THERAPEUTIC AGENT
#2661Compositions comprising macrolide and tetracycline and their uses
#2662SNS-595 and methods of using the same
#2663QUERCETIN-3-GLUCOSIDE AND USES THEREOF
#2664Methods for identifying and treating cancer patients
#2665Modified saponins for the treatment of fungal infections
#2666PNEUMATIC WRAP COMPRESSION TREATMENTS FOR VENOUS CONDITIONS
#2667Methods and Compositions for Modulating Beta Cell Proliferation
#2668Methods for inhibiting advanced glycation end product production, inhibiting fibroblast apoptosis, and/or promoting human fibroblast-collagen grating formulation using cherry blossom and cherry leaf extract
#2669Use of terminalia chebula extract for treatment of osteoarthritis
#2670Pharmaceutical compounds with the structure of ionic salts with antibiotic and anticancer action
#2671Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
#2672Transmucosal Administration of Drug Compositions for Treating and Preventing Disorders in Animals
#2673COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS
#2674Exfoliative hair retention-promoting formulation
#2675Compositions That Include Anthocyanidins and Methods of Use
#2676Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
#2677Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
#2678BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
#2679Rutin-rich extract and method of making same
#2680Prevention of Clostridium Difficile Infection in High Risk Patients
#2681Acylation derivatives of paridis saponins I, preparation method therefor and application thereof
#2682BIODEGRADABLE DRUG DELIVERY FOR HYDROPHOBIC COMPOSITIONS
#2683SOLID PHARMACEUTICAL FORMULATION WITH DELAYED RELEASE
#2684PHARMACEUTICAL ANTI-INFECTIVE COMPOSITION FOR INHALATION
#2685COMPOSITIONS FOR INACTIVATING PATHOGENIC MICROORGANISMS, METHODS OF MAKING THE COMPOSITIONS, AND METHODS OF USE THEREOF
#2686COMPOSITION AND METHOD FOR COMPOUNDED THERAPY
#2687Potentiation of antibiotic treatment with a protein-lipid complex
#2688SLEEP QUALITY IMPROVING AGENT
#2689NOVEL ANTIOXIDANT FORMULATIONS
#2690TOPICAL LIPOSOMAL COMPOSITIONS FOR DELIVERING HYDROPHOBIC DRUGS AND METHODS PREPARING SAME
#2691Cochleates made with soy phosphatidylserine
#2692Shikimate pathway inhibitors and the use thereof
#2693Treatment of Clostridium Difficile Infection in High Risk Patients
#2694Salacia compositions, methods of treatment by their administration, and methods of their preparation
#2695GLYCOSIDE DERIVATIVES AND USES THEREOF
#2696Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care
#2697Cochleates made with soy phosphatidylserine
#2698Polyhydroxylated pentacyclic triterpene acids as HMG-COA reductase inhibitors
#2699Compositions for treating obesity and insulin resistance disorders
#2700AGENTS AND DEVICES FOR AFFECTING NERVE FUNCTION